# DoseOptics LLC

> DoseOptics LLC is a Dartmouth spinoff based in Lebanon, New Hampshire that builds BeamSite, the first FDA-cleared camera system to record radiation therapy as it happens by imaging Cherenkov light - the faint glow emitted when a radiotherapy beam passes through tissue. The technology lets radiation oncology teams literally see the beam on the patient in real time, turning an invisible treatment into a video they can review, catching positioning errors and delivery anomalies that were previously undetectable.

- **Founded:** 2015
- **Headquarters:** Lebanon, New Hampshire, United States
- **Founders:** Brian Pogue (President & Co-Founder), William Ware (CEO & Co-Founder)
- **Team size:** ~16 employees
- **Products:** BeamSite, C-Dose RESEARCH, DoseRT
- **Notable:** Released the world's first radiation beam imaging system using Cherenkov light, Received FDA 510(k) clearance for BeamSite in December 2020, Raised roughly $3.4 million in NIH grant funding for clinical trials and development

## Products & services

- **BeamSite** — FDA 510(k)-cleared real-time radiation visualization system that captures Cherenkov light during external beam photon radiotherapy, imaging the dose directly on the patient with no additional ionizing radiation. Supports multiple cameras for full-body coverage and records anomalies for QA review.
- **C-Dose RESEARCH** — The company's research-grade Cherenkov imaging platform, ready to capture both photon and electron beam delivery. Installs as a fixed ceiling-mounted device or on a tripod, used for clinical and research applications.
- **DoseRT** — An advanced visualization platform associated with a collaboration in the surface-guided radiotherapy space, extending Cherenkov-based imaging into treatment workflows.

## Achievements

- Released the world's first radiation beam imaging system using Cherenkov light
- Received FDA 510(k) clearance for BeamSite in December 2020
- Raised roughly $3.4 million in NIH grant funding for clinical trials and development
- Technology deployed first at Dartmouth's Norris Cotton Cancer Center and expanding to other cancer centers
- Published peer-reviewed research including Cherenkov dose imaging in Nature Communications

## Latest updates

- **2020-12** — DoseOptics received FDA 510(k) clearance to market BeamSite for photon external beam radiotherapy.
- **2016-09** — Awarded a $2M NIH grant for further clinical trials, bringing total NIH funding to about $3.4M.
- **2015-08** — DoseOptics LLC founded as a Dartmouth spinoff by Brian Pogue and William Ware.

## Links

- Website: https://doseoptics.com
- LinkedIn: https://www.linkedin.com/company/doseoptics-llc
- Twitter/X: https://x.com/dose_optics

---

Profile page: https://yespress.io/doseoptics-llc
Published by YesPress — https://yespress.io
Last updated: 2026-08-06